During the past decade, Landeskrankenhaus Feldkirch conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Landeskrankenhaus Feldkirch" #1 sponsor was "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 10 trials, followed by "Austrian Breast & Colorectal Cancer Study Group" with 5 trials sponsored, "Bayer" with 3 trials sponsored, "Swiss Group for Clinical Cancer Research" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Landeskrankenhaus Feldkirch" #1 collaborator was "Hoffmann-La Roche" with 3 trials as a collaborator, "Amgen" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator and "ETOP IBCSG Partners Foundation" with 2 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Landeskrankenhaus Feldkirch" are "Breast Cancer" (3 trials), "Chronic Kidney Disease" (2 trials), "Esophageal Cancer" (2 trials), "Glioblastoma Multiforme" (2 trials) and "Leukemia, Lymphocytic, Chronic, B-Cell" (2 trials). Many other conditions were trialed in "Landeskrankenhaus Feldkirch" in a lesser frequency.

Most popular intervention types in "Landeskrankenhaus Feldkirch" are "Drug" (42 trials), "Radiation" (7 trials), "Biological" (6 trials), "Procedure" (6 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Cisplatin" (5 trials), "Rituximab" (5 trials), "Cetuximab" (3 trials) and "Alemtuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Landeskrankenhaus Feldkirch" are 49 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Landeskrankenhaus Feldkirch". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 31 completed trials in Landeskrankenhaus Feldkirch, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Landeskrankenhaus Feldkirch, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".